Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
Panelists discuss how clinicians manage suboptimal responders by focusing on stability rather than complete dryness, using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback